Platform randomised controlled trial of point of care diagnostics for enhancing the quality of antibiotic prescribing for community-acquired acute respiratory tract infection in ambulatory care in Europe

niversity of Oxford0 个研究点目标入组 2,649 人开始时间: 2020年12月11日最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•1. Male or female, aged 1 year and older
•2. Consulting with symptoms of lower respiratory tract infection where cough is the predominant symptom (<28 days); or, symptoms of an upper respiratory tract infection (<14 days) where a sore throat is the dominant symptom; and where the clinician is considering/has decided to prescribe an antibiotic
•3. Is able and willing to comply with all trial requirements
•4. Participant or legal guardian(s) of a child is willing and able to give informed consent according to national regulations

•1. Patients with only nasal, ear or rhinosinusitis symptoms
•2. Patients who have tested positive to SARS-CoV-2 within 28 days of onset of symptoms
•3. Patients with any serious condition associated with immunocompromised (long term oral steroids or immunosuppressants, terminal cancer)
•4. Patients for whom the clinician decides on immediate hospital admission
•5. Patients who will not be able to participate in the study because they do not understand the local language; are terminally ill; have a serious psychiatric disorder; or judgement of the recruiting clinician deems ineligible

发起方